Fibromyalgia Relief with Chiropractic

If you suffer from fibromyalgia, you are not alone, as Spinal Health Chiropractic Center sees many patients with this particular problem in our Largo chiropractic practice. Actually, the Centers for Disease Control and Prevention (CDC) estimates that roughly two percent of all adults in the US have fibromyalgia issues. Thankfully, chiropractic adjustments is one treatment option that can provide positive results.

Research Supports Chiropractic Therapy Eases Fibromyalgia Issues

In a study released in mid-2015, 215 adults with fibromyalgia were evaluated based on factors ranging from pain to quality of sleep to the levels of depression and anxiety they felt. Then they were split into two groups with one group receiving a multi-modal therapy program for three months and the second group receiving the same approach with the addition of chiropractic adjustments (specifically, to the upper neck tissues) for the same length of time.

The individuals who received chiropractic adjustments in addition to the multi-modal treatment program reported greater benefits in all areas (pain, sleep, depression, and anxiety) at three months post-treatment when compared to the study people who received multi-modal treatment without chiropractic care. In addition, those positive results were long-lasting as the people reported continued improvement one full year later.

Fibromyalgia issues can substantially diminish your quality of life, both mentally and physically. If you're struggling with fibromyalgia, we might be able to help.

You don't have to suffer! To see what Spinal Health Chiropractic Center can do for your fibromyalgia discomfort, call our Largo chiropractic office today.

Research

• Fibromyalgia. Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/arthritis/basics/fibromyalgia.htm on November 2, 2015.
• Moustafa I & Diab A. (2015, July). The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial. Rheumatology International;35(7):1163-74.